Associated Papers
Mouse models of NADK2 deficiency analyzed for metabolic and gene expression changes to elucidate pathophysiology.
Murray GC et al.
Human Molecular Genetics, 2022
Clinical heterogeneity of mitochondrial NAD kinase deficiency caused by a NADK2 start loss variant.
Pomerantz DJ et al.
American Journal of Medical Genetics. Part A, 2018
Lysine Restriction and Pyridoxal Phosphate Administration in a NADK2 Patient.
Tort F et al.
Pediatrics, 2016
Select a paper to view details